Picture Kentro Design Corporate and Web Design Berlin 650x65px

Document › Details

AstraZeneca plc. (12/12/20). "Press Release: AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development [Not for any jurisdicition where violation of relevant laws]".

	Organisation	AstraZeneca plc (LSE: AZN)
	Group	AstraZeneca (Group)
	Organisation 2	Alexion Pharmaceuticals Inc. (Nasdaq: ALXN)
	Group	Alexion (Group)
	Product	DRUGS, ORPHAN
	Product 2	pharmaceutical
	Index term	Alexion–AstraZeneca: investment, 202012– acquisition $39b with $13.4b in cash + $25.6b in ADSs Alexion shareholders will own 15% of combined firm
	Person	Soriot, Pascal (AstraZeneca 201210– CEO before Roche COO Pharma Div before Genentech CEO)
	Person 2	Hantson, Ludwig Norbert Michel (Alexion 201703– CEO before Baxalta/Baxter)

Original document
accessed by [iito] on 2020-12-13

Record changed: 2020-12-23

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

More documents for AstraZeneca (Group)

[1] AstraZeneca plc. (12/30/20). "Press Release: AstraZeneca’s COVID-19 Vaccine Authorised for Emergency Supply in the UK"....
[2] Exscientia Ltd.. (11/10/20). "Press Release: Exscientia Recruits Industry Innovator Garry Pairaudeau as Chief Technology Officer"....
[3] Fusion Antibodies Ltd.. (11/6/20). "Press Release: Fusion Antibodies Announce New Senior Hire to Support Innovation"....
[4] Nvidia Corporation. (10/5/20). "Press Release: Nvidia Building UK’s Most Powerful Supercomputer, Dedicated to AI Research in Healthcare". Santa Clara, CA....
[5] Oxford BioMedica plc. (9/1/20). "Press Release: Oxford Biomedica Signs Supply Agreement with AstraZeneca to Expand Manufacturing Support of COVID-19 Vaccine Candidate, AZD1222". Oxford....
[6] Cellink AB. (8/27/20). "Press Release: Cytena and AstraZeneca Collaborate to Develop Plate Based Microbioreactors for Cell Line Development Workflows"....
[7] Redx Pharma plc. (8/4/20). "Press Release: Redx Signs Out Licensing Agreement with AstraZeneca". Alderley Park....
[8] ImaginAb, Inc.. (3/30/20). "Press Release: ImaginAb Announces Licensing Deal with AstraZeneca for CD8 ImmunoPET Technology". Los Angeles, CA....
[9] Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces R&D Update". London....
[10] Silence Therapeutics plc. (3/25/20). "Press Release: Silence Therapeutics Announces Collaboration with AstraZeneca to Discover and Develop siRNA Therapeutics for Cardiovascular, Renal, Metabolic and Respiratory Diseases". London....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]